Should Scientists Use “Race” as a Proxy for Genetics?
Nature, last month (paywall):
The US Food and Drug Administration (FDA) will soon require [based on new federal legislation] researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants…. The diversity requirement arrives in the wake of a 2022 report from the US National Academies of Sciences, Engineering and Medicine, which found that, although the representation of white women in clinical trials has improved, progress has “largely stalled” for minority racial and ethnic groups.
Grappling with the deep history of racism in Western science, the National Academies of Science on Tuesday released guidelines recommending that scientists not use race as a category in genetic studies.
The guidelines, produced in response to a directive from the National Institutes of Health, noted that racial categories were poor proxies for genetic diversity and that social and env
Article from Latest